Glanbia Plc · EURONEXT:GL9
Glanbia — Q3 2022 Earnings Presentation
12 slides from Glanbia's earnings presentation, Nov 3, 2022
Slide 1: Glanbia plc Q3 2022
Glanbia plc Q3 2022 3 November 2022 Group Managing Director Group Finance Director
Slide 2: Important notice
2 Glanbia plc | Q3 2022 presentation Important notice This presentation contains forward-looking statements. These statements have been made by the Directors in good faith based on the information available to them up to the time of their approval of this presentation. Due to the inherent uncertaint
Slide 3: Q3 2022 YTD Highlights
3 Glanbia plc | Q3 2022 presentation Q3 2022 YTD Highlights 23.1% constant currency revenue growth – all pricing actions in 2022 now complete Consumption trends continue to be strong in the GPN performance nutrition and healthy lifestyle portfolios Revised ambition for a 50% reduction (previously a
Slide 4: Q3 2022 YTD Revenue overview
4 Glanbia plc | Q3 2022 presentation Q3 2022 YTD Revenue overview Revenue growth primarily driven by pricing actions Q3 2022 YTD Revenue Growth (Constant Currency) Volume Price LFL* Acquisition Total BRANDED -1.2% 15.6% 14.4% - 14.4% GPN TOTAL -2.2% 15.4% 13.2% 0.5% 13.7% NS -3.2% 17.7% 14.5% 5.8% 2
Slide 5: FY 2022 Outlook
5 Glanbia plc | Q3 2022 presentation FY 2022 Outlook LFL* revenue EBITA EBITA Margin OCF growth % GPN & GN GPN: broadly in line vs. PY 80% OCF conversion GPN - low teens growth v PY GN NS: c.-100bps vs. PY GN NS - strong double-digit Adjusted EPS growth of 10% to 13% constant currency (26% to 29% re
Slide 6: GPN Q3 2022 YTD update
6 Glanbia plc | Q3 2022 presentation GPN Q3 2022 YTD update Branded LFL* Revenue Revenue Growth +14.4% VOLUME -1.2% PRICE +15.6% Revenue +13.4% in Americas and +14.5% in International Significant pricing action taken across all brands Continued volume momentum in the performance nutrition and health
Slide 7: Leading brands in performance & lifestyle nutrition
7 Glanbia plc | Q3 2022 presentation Leading brands in performance & lifestyle nutrition Performance Nutrition Healthy Lifestyle Weight Management D2C % GPN Revenue 54.2% 16.8% 15.8% 5.7% YTD LFL* Revenue +22.6%cc +26.1%cc -13.2%cc +11.3%cc Growth US Consumption** +32.9% +15.8% -18.2% - • Continued
Slide 8: GN - Nutritional Solutions Q3 2022 YTD update
8 Glanbia plc | Q3 2022 presentation GN - Nutritional Solutions Q3 2022 YTD update GN NS Revenue Revenue Growth +20.3% VOLUME -3.2% PRICE +17.7% ACQUISITIONS +5.8% Volume decline primarily driven by dairy ingredients and expected to largely recover in Q4 Pricing action across all elements of the por
Slide 9: Finance Q3 2022 review
Finance Q3 2022 review
Slide 10: Q3 2022: Strong Balance Sheet
10 Glanbia plc | Q3 2022 presentation Q3 2022: Strong Balance Sheet Net debt €749.6m FY 2022 expected to be €173m returned in share €65m - €70m buybacks in 2022 YTD 80% OCF conversion for FY 2022 Total committed facilities of €1.3 billion
Slide 11: Conclusion
11 Glanbia plc | Q3 2022 presentation Conclusion Category trends in Better Nutrition remain positive for GPN and NS Strong year-on-year EBITA growth expected in H2 2022 Guidance updated for FY 2022. The Group expects 10% to 13% growth in adjusted EPS, constant currency (26% to 29% growth reported at
Slide 12: Questions
Questions